Revance Promotes Conor Gallagher to Chief Scientific Officer
Conor Gallagher, PhD, is now the Chief Scientific Officer at Revance Therapeutics. Mr. Gallagher joined Revance in April 2018 to lead the Medical Affairs group. Over the past few years, he expanded his role to oversee R&D, process development and analytical development under the umbrella of Scientific Innovation. Additionally, he leads Revance’s team working on […]